BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20863652)

  • 1. [Lymphoscintigraphic exploration in the limbs lymphatic disease].
    Baulieu F; Lorette G; Baulieu JL; Vaillant L
    Presse Med; 2010 Dec; 39(12):1292-304. PubMed ID: 20863652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lower limb edema and steatorrhea: value of scintigraphic technics].
    Bourgeois P; Munck D; Leduc O
    Rev Med Brux; 2003 Apr; 24(2):101-4. PubMed ID: 12806877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of SPECT/CT imaging to the lymphoscintigraphic investigations of the lower limb lymphedema.
    Baulieu F; Bourgeois P; Maruani A; Belgrado JP; Tauveron V; Lorette G; Vaillant L
    Lymphology; 2013 Sep; 46(3):106-19. PubMed ID: 24645534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison study of radionuclide lymphoscintigraphy and dynamic magnetic resonance lymphangiography for the diagnosis of extremity lymphedema].
    Liu NF; Lu Q; Liu PA; Yan ZX; Wu XF
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Jul; 27(4):241-5. PubMed ID: 22097305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoscintigraphic analysis in chromoblastomycosis.
    Ogawa MM; Alchorne MM; Barbieri A; Castiglioni ML; Penna AP; Tomimori-Yamashita J
    Int J Dermatol; 2003 Aug; 42(8):622-5. PubMed ID: 12890106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized lymphoscintigraphy and diagnostics of lymphatic oedema of the lower extremities.
    Dabrowski J; Merkert R; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2008; 11(1):26-9. PubMed ID: 19173185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients.
    Weissleder H; Weissleder R
    Radiology; 1988 Jun; 167(3):729-35. PubMed ID: 3363131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphedema secondary to breast cancer treatment: possibility of diagnostic and therapeutic prevention].
    Campisi C; Boccardo F; Zilli A; Maccio A; Napoli F; Ferreira Azevedo W; Fulcheri E; Taddei G
    Ann Ital Chir; 2002; 73(5):493-8. PubMed ID: 12704989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of SPECT/CT lymphoscintigraphy in the initial assessment of secondary extremity lymphedema patients.
    Yoon HJ; Woo KJ; Kim JY; Kang SY; Moon BS; Kim BS
    Sci Rep; 2023 Nov; 13(1):19494. PubMed ID: 37945581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities.
    Cambria RA; Gloviczki P; Naessens JM; Wahner HW
    J Vasc Surg; 1993 Nov; 18(5):773-82. PubMed ID: 8230563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical yield of SPECT/CT for the assessment of lymphatic transport disorders. First experiences].
    Weiss M; Landrock S; Wallmichrath J; Baumeister RG; Bartenstein P; Frick A
    Nuklearmedizin; 2013 Dec; 52(6):235-43. PubMed ID: 24051759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema.
    Szuba A; Shin WS; Strauss HW; Rockson S
    J Nucl Med; 2003 Jan; 44(1):43-57. PubMed ID: 12515876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphedemas of the lower limbs: a lymphoscintigraphic study].
    Cestari SC; Petri V; Castiglioni ML; Lederman H
    Rev Assoc Med Bras (1992); 1994; 40(2):93-100. PubMed ID: 7820157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoscintigraphic evaluation in patients after erysipelas.
    de Godoy JM; de Godoy MF; Valente A; Camacho EL; Paiva EV
    Lymphology; 2000 Dec; 33(4):177-80. PubMed ID: 11191659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of upper limb lymphedema from routine lymphoscintigraphic examinations.
    Gebouský P; Kárný M; Krízová H; Wald M
    Comput Biol Med; 2009 Jan; 39(1):1-7. PubMed ID: 19041964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy for interpretation of changes of cervical lymph node function in patients with oral malignant tumors: comparison of Tc-99m-Re and Tc-99m-HSA-D.
    Sato T; Yamaguchi K; Morita Y; Noikura T; Sugihara K; Matsune S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):525-37. PubMed ID: 11027392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoscintigraphy in angiomyomatous hamartomas and primary lower limb lymphedema.
    Bourgeois P; Dargent JL; Larsimont D; Munck D; Sales F; Boels M; De Valck C
    Clin Nucl Med; 2009 Jul; 34(7):405-9. PubMed ID: 19542941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncontrast three-dimensional magnetic resonance imaging vs lymphoscintigraphy in the evaluation of lymph circulation disorders: A comparative study.
    Liu N; Wang C; Sun M
    J Vasc Surg; 2005 Jan; 41(1):69-75. PubMed ID: 15696047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for Study of the Deep Subfascial Lymphatic Vessels During Lymphoscintigraphy for the Diagnosis of Peripheral Lymphedema.
    Campisi CC; Ryan M; Villa G; Di Summa P; Cherubino M; Boccardo F; Campisi C
    Clin Nucl Med; 2019 Feb; 44(2):91-98. PubMed ID: 30516673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of radionuclide lymphoscintigraphy and dynamic magnetic resonance lymphangiography for investigating extremity lymphoedema.
    Liu NF; Lu Q; Liu PA; Wu XF; Wang BS
    Br J Surg; 2010 Mar; 97(3):359-65. PubMed ID: 20101589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.